Fischer Medical Ventures Firms Up Marketing Rights of Nanyang Biologics’ Transformative Nutraceuticals for India, Middle East & ASEAN

Fischer Medical Ventures Limited, a pioneering force in the healthcare industry, has secured marketing rights for Nanyang Biologics’ transformative nutraceuticals in India, the Middle East, and the ASEAN region. Nanyang Biologics, a leading drug discovery company, leverages advanced technologies like AI, machine learning, and virtual collaboration to disrupt the drug discovery industry. They have curated a vast Natural Compound Library encompassing over 40,000 compounds from tropical flora and employ advanced Metagenomics and Metaproteomics Analysis. Fischer Medical Ventures, known for its affordable and accessible medical diagnostic and imaging technologies, is moving into the preventative healthcare space with this strategic partnership.